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The kidneys are essential for maintaining homeostasis, are responsible for the reabsorption of water, glucose and amino acids, 
and filter the blood by removing waste. Acute kidney injury (AKI) is a syndrome characterized by the rapid loss of renal ex-
cretory function and the accumulation of end metabolic products of urea and creatinine. AKI is associated with the later de-
velopment of chronic kidney disease and end-stage kidney disease, and may eventually be fatal. Early diagnosis of AKI and 
assessments of the effects of treatment, however, are challenging. The pathophysiological mechanism of AKI is thought to be 
the imbalance between oxygen supply and demand in the kidneys. We have assessed the ability of arterial spin labeling (ASL) 
perfusion magnetic resonance imaging (MRI), without the administration of contrast media, to quantify renal blood flow (RBF) 
non-invasively. We found that RBF was significantly lower in AKI patients than in healthy volunteers. These results suggest 
that ASL perfusion MRI, a noninvasive measurement of RBF, may be useful in the early diagnosis of AKI. 
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Acute kidney injury (AKI) is a frequently observed condi-
tion linked with the later development of chronic kidney 
disease, end-stage kidney disease, and mortality. AKI has 
been reported to affect more than 5000 per million people 
not on dialysis therapy and 295 per million on dialysis 
therapy per year [1–3]. The advent of the RIFLE (risk, in-
jury, failure, loss, end-stage kidney disease) and Acute 
Kidney Injury Network (AKIN) criteria has improved the 
diagnosis of AKI [4], and decreased renal blood flow (RBF), 
which causes renal ischemia, has been proposed as central 
to the pathogenesis of septic acute renal failure [5]. These 
criteria, however, have been based on serum creatinine 
concentration and urine output, both of which have rela-
tively poor specificity and sensitivity during the early period 
of AKI [6–9]. At present, therefore, there are no effective 
biomarkers for AKI, making early diagnosis of AKI and the 
assessment of the effects of therapy difficult [10].  
Noninvasive functional magnetic resonance imaging 
(MRI) provides a variety of effective methods to evaluate 
renal function in vivo without administration of contrast 
media. The arterial spin labeling (ASL) perfusion technique, 
in which inflowing blood is labeled magnetically, can be 
used in the absolute quantification of renal blood flow 
(RBF), especially in patients with impaired renal function 
[11–15]. ASL was found to be better able to quantify corti-
cal RBF than dynamic contrast enhanced MRI [16]. The 
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reproducibility of the flow-sensitive alternating inversion 
recovery (FAIR) ASL perfusion technique over a broad 
range of renal function has been demonstrated in the corti-
ces of native and transplanted kidneys [17]. Moreover, by 
measuring kidney perfusion, ASL demonstrated a potential 
capability for assessing renal disease in both native and 
transplanted kidneys [12,17,18]. To our knowledge, howev-
er, quantitative ASL analysis has not been used in the diag-
nosis of AKI. We therefore performed a pilot study to in-
vestigate the feasibility of noninvasive ASL perfusion MRI 
in the diagnosis of AKI. 
1  Materials and methods 
1.1  Subjects 
From October 1, 2011 to December 1, 2012, 13 AKI pa-
tients and 18 healthy volunteers were recruited. Patients 
were included if they (a) were adults diagnosed with AKI 
by referring nephrologists, (b) were scheduled to undergo 
percutaneous renal biopsy three days after MR examination 
and prior to therapy, (c) had no signs of other kidney dis-
eases, such as renal artery stenosis and urolithiasis, as 
shown by ultrasonography in our hospital while being in 
patients, and (d) had normal cardiac function. Healthy vol-
unteers were included if they (a) were adults with no history 
of renal or cardiac diseases, and (b) had normal serum cre-
atinine concentrations one week before MR scanning.  
Patients underwent MR examinations before initial of 
therapy. All subjects refrained from food and fluids for 6 h 
and were trained in breath-holding techniques training be-
fore MR examination. Serum creatinine concentrations were 
measured in all subjects before MR examination. 
This prospective study was compliant with the Health 
Insurance Portability and Accountability Act (HIPAA) and 
was approved by our institutional review board. All subjects 
provided written informed consent and were compatible 
with MR scanning. 
1.2  MR protocols 
All examinations were performed on a 3.0T MR scanner 
(Signa Excite; GE Healthcare, Milwaukee, WI) using a 
commercial Torso PA coil (GE Medical Systems). The 
scout images were scanned with a gradient echo sequence in 
three oblique planes through the center of each kidney. 
Oblique-coronal T2-weighted imaging through the center of 
the kidney was performed for anatomical evaluation using a 
single shot fast spin echo (SSFSE) sequence with the param-
eters: TR=1100 ms, TE=60 ms, slice thickness=5 mm, 1 mm 
interval, matrix 192×256, flip angle 130°, bandwidth=    
62 kHz, FOV 35–40 cm.  
ASL images were acquired for quantitative measure-
ments of RBF by applying the fluid alternating inversion 
recovery (FAIR) sequence with the combination of a sin-
gle-shot fast spin-echo (SSFSE) imaging (FAIR-SSFSE). 
One single oblique coronal slice of ASL was scanned in the 
same position through the center of the kidney with the pa-
rameters: field of view (FOV)=40 cm, matrix=128×128, 
slice thickness=5 mm, TR=3500 ms, TE=60 ms, flip angle = 
90°, bandwidth=62.5 kHz. The slab thickness was set at 20 
mm for section selective inversion in the FAIR preparation, 
to avoid artifacts from incompletely inverted spins at the 
margins of the readout slice, with no feeding vessels in-
cluded.  
At the beginning of the scanning process, inversion ra-
diofrequency pulses were used to label the protons in the 
arterial blood feeding both kidneys, with the magnetically 
tagged blood acting as an endogenous tracer. All six ASL 
images were scanned at the same slice, including three tag 
images with section selective inversion and three control 
images with global inversion. The inversion time (TI) be-
tween the tag and control images was fixed at 1400 ms to 
ensure the tagged protons reached the capillary bed and 
exchanged with protons in the surrounding tissue; the tag 
image was then subtracted from the control image to re-
move signals of static tissue, yielding residual signals for 
quantification of RBF. M0 images were acquired using the 
SSFSE sequence, with the same parameters as the prior 
FAIR-SSFSE sequence without FAIR preparation, and the 
repetition time (TR) was set at 6 s to allow for the complete 
recovery of blood signals between measurements.  
All participants were instructed to hold their breath for 
20–30 s during each acquisition, with ASL imaging per-
formed twice. The total acquisition time for ASL imaging 
was limited to 1 min. 
1.3  Data processing 
A quantitative model for calculating RBF from FAIR tech-
niques, using extended Block equations [19], was used to 
simulate ΔM(TI), the difference in longitudinal magnetiza-
tion between FAIR images with section-selective prepara-
tion and those with global preparation: 
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where M is the difference in magnetization between sec-
tion-selective (Msel) and nonselective (Mnonsel) measurements; 
M0 represents the tissue equilibrium magnetization per unit 
mass of tissue; T1 is the longitudinal relaxation time of tis-
sue; f is the perfusion rate (usually expressed in milliliters 
per 100 g per minute); and  is the blood-tissue water parti-
tion coefficient, which is thought to be nearly constant at 
0.80. Perfusion maps can be calculated pixel-by-pixel by 
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All ASL images were post-processed in Matlab software 
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(MathWorks Inc. Natick, MA). After correction for motion 
artifacts, the final M images were generated by averaging 
and subtracting section-selective and global inversion im-
ages acquired in two sets. The T1 values for the renal cortex 
and medulla were set at 1142 and 1545 ms, respectively [20, 
21]. Pixels with perfusion values higher than 600 mL min1 
100 g1 in the cortex and higher than 250 mL min1 100 g1 
in the medulla were excluded from the RBF evaluation. 
Multiple regions of interest (ROIs) with areas of 50–100 
mm2 in the perfusion map, were drawn in the cortex and 
medulla of both kidneys (Figure 1) [16], and RBFs in the 
cortex and medulla were separately calculated by averaging 
all ROI data in these areas. The measurements were per-
formed on both ASL images for each subject, and the aver-
aged value was used as the final RBF. 
1.4  Statistical analysis 
All statistical analyses were performed using SPSS 16.0 
(SPSS Inc., Chicago, IL). Quantitative data are presented as 
mean±standard deviation (SD). The RBFs of the cortical 
and medullary kidney were compared using independent t 
tests. The correlations between serum creatinine concentra-
tions and the RBFs of cortical and medullary kidney were 
determined. A P-value less than 0.05 was defined as statis-
tically significant. 
2  Results 
MR examinations were performed in 13 patients (eight 
males and five females, ranging in age from 31 to 67 years) 
and 18 healthy volunteers (11 males, seven females, ranging 
in age from 32 to 66 years). Although all received respira-
tory coaching, two patients were unable to hold their breath 
and were excluded for breathholding failure, which resulted 
in unsolved motion artifacts even using the nonlinear image 
registration method. Finally, 11 patients (seven males and 
four females, ranging in age from 31 to 67 years) and the 18 
healthy volunteers were included. There were no statistical-
ly significant between-group differences in age and sex dis-
tribution. Subsequent percutaneous renal biopsy in these 11 
patients showed that six had acute tubular interstitial nephritis, 
two had membranous nephropathy, two had IgA nephropathy, 
and one had granulomatous interstitial nephritis. 
RBFs were measured in the cortex and medulla of each 
kidney in both groups, with each group showing similar 
RBFs in the cortex and medulla of the left and right kidneys 
(Table 1). 
Perfusion values in the control group ranged from 357 to 
426 mL min1 100 g1 in the cortex and from 107 to 126 mL 
min1 100 g1 in the medulla, similar to previous findings 
[15,17,22]. RBFs in patients with AKI ranged from 223 to  
 
 
Figure 1  Regions of interests (ROIs) in the kidneys. Multiple ROIs, 50–100 mm2 in area, were drawn in the renal cortex (A) and medulla (B), with aver-
aged values calculated as the cortical and medullary RBFs, respectively. 
 
Table 1  RBFs (mL min1 100 g1) of the cortex and medulla in the left 
and right kidneys of the control and AKI groups 
 Left Right P-value 
Control    
Cortex 396.7±17.6 400.9±21.3 0.78 
Medulla 121.3±18.7 115.9±20.2 0.61 
Study    
Cortex 285.8±44.1 294.9±51.2 0.43 
Medulla 110.7±18.2 101.6±15.5 0.41 
Table 2  RBFs (mL min1 100 g1) of the cortex and medulla in the con-
trol and AKI groups 
 Control Study P-value 
Cortex 398.8±19.7 291.8±47.1 <0.01 
Medulla 118.0±19.8 105.7±17.0 <0.01 
 
392 mL min1 100 g1 in the cortex and from 89 to 116 mL 
min1 100 g1 in the medulla, with both being significantly 
lower than in the healthy volunteers (Table 2). Functional 
perfusion maps of ASL showed differences between the 
study and control groups (Figure 2). 
Serum creatinine concentrations ranged from 52 to 111 
mol L1 in the control group and from 65.8 to 752 mol 
L1 in the AKI group. In the control group, RBF in the cor-
tex showed a significant positive correlation with serum 
creatinine concentration (r=0.71, P=0.001), with no sig-
nificant correlation in the medulla (r=0.39, P=0.24). In the 
AKI group, however, RBF in the cortex (r=0.31, P=0.28) 
and medulla (r=0.27, P=0.48) was not correlated with se-
rum creatinine concentration (Figure 3). 
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Figure 2  Oblique coronal image of ASL and perfusion map of subjects in the (A and B) and AKI (C and D) groups. A and B, Results in a 32-year-old male 
volunteer, showing a clear corticomedullary edge of the kidney (A), and normal renal blood flow (RBF) (cortex, 401.6 mL min1 100 g1; medulla, 123.0 mL 
min1 100 g1) (B). C and D, Results in a 48-year-old man diagnosed with tubular interstitial nephrology, showing an obscure boundary between the cortex 
and medulla of the kidney (C), with lower RBFs in the cortex (272.2 mL min1 100 g1) and medulla (97.6 mL min1 100 g1) (D). 
3  Discussion 
To our knowledge, this is the first study to assess RBF using 
ASL MRI in patients with AKI. The results suggest that this 
noninvasive method, using FAIR-SSFSE sequences, yields 
reliable quantitative measurements of RBF in both AKI 
patients and healthy volunteers without administration of 
contrast media. Reduction in RBF in both the cortex and 
medulla can help diagnose AKI, especially for patients with 
impaired renal function.  
ASL imaging, a noninvasive functional MRI technique, 
has been widely used to assess perfusion changes in patients 
with cerebral artery diseases, and has yielded promising 
results [23–25]. Application of ASL to the kidneys, however, 
is limited by respiration and magnetic susceptibility artifacts 
in abdominal organs. Using the nonlinear image registration 
method, ASL images can be acquired with acceptable qual-
ity for calculating perfusion maps of RBF. In addition, the 
background suppression technique was used to zero static 
tissue to enhance the low signal-to-noise ratio in perfusion 
maps, thus increasing perfusion signal [26]. ASL imaging 
with FAIR true FISP has been found suitable for quantita-
tive assessment of RBF in patients with renal artery stenosis 
[15]. Moreover, ASL imaging has been used in a mouse 
renal cell carcinoma model to characterize early changes in 
response to antiangiogenic therapy, with these changes pre-
dicting later therapeutic responses [14]. We found that, in 
healthy volunteers, mean RBF was (398.8±19.7) mL min1 
100 g1 in the cortex and (118±19.8) mL min1 100 g1 in 
the medulla, with no significant differences between the left 
and right kidneys. These results are consistent with studies 
showing the reliability and reproducibility of the ASL tech-
nique.  
AKI refers to a clinical syndrome characterized by rapid 
decreases in renal function within a few hours to a few days, 
with accumulation of products of nitrogen metabolism such 
as creatinine and urea [10]. Causes of AKI vary from re-
duced kidney perfusion and prerenal azotemia to direct re-
nal toxicity and postrenal obstruction, with AKI accounting 
for 1.9% of hospital inpatients [27]. Although increased 
serum creatinine and urea concentrations are the standard 
diagnostic laboratory criteria for AKI, they are relatively 
insensitive, becoming abnormal only when glomerular fil-
tration rate decreases by more than 50%. Furthermore, they 
do not show dynamic changes in glomerular filtration rates 
[28]. Although several novel biomarkers were recently re- 
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Figure 3  Correlation between serum creatinine concentration and cortical and medullary renal blood flow (RBF) in the control (A and B) and AKI (C and 
D) groups. A, Cortical RBF was positively correlated with serum creatinine concentration in the control group (r=0.71, P=0.001). B–D, There were no 
correlations between serum creatinine concentration and medullary RBF in the control group (B) and between serum creatinine and cortical (C) and medul-
lary (D) RBFs in the AKI group. 
ported to diagnose AKI earlier and to reflect dynamic alter-
ations to therapy, their clinical usefulness requires addition-
al confirmation [6,7,29]. The dominant mechanism in the 
pathogenesis of AKI is a significant reduction in RBF [30]. 
Although multiple modalities have been used to measure 
RBF, including nuclear medicine and contrast enhanced CT, 
impaired renal function restricts their application. 
The most important advantages of ASL in quantifying 
RBF are that it is completely non-invasive method and does 
not require administration of contrast media. This prevents 
any potential risk of contrast medium induced nephrology, 
which is of extreme importance for patients with impaired 
renal function. ASL MRI has been used in patients with 
impaired renal allograft function, and its reproducibility and 
reliability have been confirmed [11,17]. To assess the sta-
bility of ASL, each sequence was scanned twice in each 
participant, with RBF determined by the average of the two 
perfusion values. We found that the renal perfusion exami-
nation based on our FAIR SSFSE sequence was robust, with 
the main perfusion signal recorded by this sequence coming 
from low velocity spins in capillary blood in the steady state, 
which stayed in the imaging slice for a relatively long  
period of time. RBF was significantly lower in AKI patients 
than in healthy volunteers, in accordance with the patho-
physiological changes that occur during AKI [5,30]. There-
fore, this noninvasive imaging modality is potentially capa-
ble of diagnosing AKI in patients with impaired renal func-
tion. 
To date, AKI has been diagnosed from increases in se-
rum creatinine concentration [10,28]. This relatively insen-
sitive marker of glomerular filtration rate was found to be 
affected by many factors, including muscle mass, age, sex, 
muscle injury, use of steroids and aggressive fluid resuscita-
tion [10]. To avoid these factors, all subjects were evaluated 
after a 6-h fast; moreover, their demographic and clinical 
characteristics were similar. The only positive correlation 
we observed between serum creatinine and RBF was in the 
cortex of the control group. The absence of a correlation 
between medullary RBF and serum creatinine in patients 
with AKI may have resulted from our inclusion of patients 
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with different pathological types and the limited numbers of 
patients. Future studies, involving more patients and those 
with uniform pathology, are required. 
This study had several limitations. First, the absence of a 
gold standard for RBF limited comparisons of quantitative 
measurements of ASL perfusion results. However, FAIR-ASL 
has shown good correlation with standard references [15,16], 
and our results were consistent. Second, we assessed a lim-
ited number of patients with AKI and these had different 
pathological types. Additional studies with larger numbers 
of patients are therefore required. Third, we assumed that 
the renal T1 relaxation times were similar in AKI patients 
and healthy volunteers. However, the T1 relaxation times of 
the kidneys may change in patients with AKI; this should be 
evaluated in future studies. 
In conclusion, noninvasive perfusion ASL MRI is feasi-
ble for the quantitative measurement of RBF in AKI pa-
tients without the need to administer contrast media. The 
significantly lower cortical, medullary and global kidney 
RBFs in AKI patients than in healthy volunteers suggest 
that this method may be useful in the diagnosis of AKI. 
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